Therefore, the loss of PLK1 or pharmacological inhibition of PLK activity resulted in slower cell proliferation concomitantly with spindle checkpoint blockade and G2/M phase arrest in tumor cells26,27. The gene discussed is PLK1; the disease is neoplasm.